Catalogue > Proteins & Enzymes > Bioactive Proteins > P2273.9505

PLP (139-151) 5 mg - P2273.9505

250,00 EUR

excl. Shipping costs Product No.: P2273.9505


Package Size: 5 mg Multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS), is characterised by primary demyelination. It is widely thought that this is the result of an autoimmune attack against myelin components. Potential target antigens in MS are proteins of the myelin sheath such as myelin oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and proteolipid protein (PLP). Experimental autoimmune encephalomyelitis (EAE) has proven to be a particularly useful animal model. T cell epitopes of MOG for the induction of EAE in mice have been identified.

pdf PLP (139-151) Productdetails (pdf)

Source: synthetic

Technical Data: sequence: HCLGKWLGHPDKF; purity: >95% (HPLC).

Shipping / Storing Information: shipped at RT, store at -20°C

Productnumber: P2273.9505

changedate: 1.1.2012


Print product data sheet

Customers who bought this product bought also the following products:

RIIGL (95%) 1 mg - P2257.9501
129,00 EUR
excl. Shipping costs
DirectBlood Mastermix 50 rxn - M3008.0050
145,00 EUR
excl. Shipping costs
Proteinase K solution (20mg/mL) 1 mL - M3037.0001
10,50 EUR
excl. Shipping costs
Proteinase K powder (>30U/mg) 1 g - M3036.1000
375,00 EUR
excl. Shipping costs
HIV-1 p17 Gag (77-85) 5 mg - P2278.9505
196,00 EUR
excl. Shipping costs
MAGE-3 antigen (271-279) 5 mg - P2282.9505
169,00 EUR
excl. Shipping costs